M

Moleculin Biotech
D

MBRX

4.00000
USD
0.08
(2.04%)
قبل الجلسة
حجم التداول
36
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
12,316,916
أصول ذات صلة المقالات

العنوان: Moleculin Biotech Inc

القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.